Loading search results
ICARUS
Physiological Phenotyping
Sponsor study identifier
interventional
80
2 countries
2
Study Start
November 1, 2025
Actual (reported)Primary Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The escalating environmental heat-stress associated with global warming is a societal challenge with large and potential harmful consequences for humans. Excess morbidity and mortality during heat waves provides strong evidence for fatal outcomes. However, it is unclear why some people are particularly vulnerable and get sick from hyperthermia, while others adapt and tolerate exposure. The Icarus project aims to provide a psycho-physiological framework for improved mitigation of the health threats associated with global warming. Combining expertise in integrative thermal physiology, pharmacology, photobiology, psychology and machine learning, we will collaborate on comprehensive cross-scientific studies using controlled lab-exposure combined with investigations in ecological settings including vulnerable and highly tolerant people across populations from northern to southern Europe. Advanced algorithms will be developed to generate personalized alerts and advising based on behavioral patterns, psychological profiling, predicted vulnerability and willingness to adopt resilience-building strategies. Global warming is projected to continue towards the end of the 21st century and constitutes an increasing threat to human health unless we as individuals and collectively become better in preventing acute effects, as well as devise sustainable strategies to limit further anthropogenic warming of the climate system. Acutely, improved guidance is important for both individual and public health, where Icarus aims at providing a highly improved basis for preventing heat-related disease, advising or nudging people towards pro-health behavior, including smarter use of technologies to mitigate heat stress, or adjusting medication to reduce adverse effects during heat events. In support of the sustainability agenda, our framework also forms a novel basis for developing advising algorithms relevant for optimization of climate change mitigation policy-making.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 1, 2025
Actual (reported)February 20, 2026
Actual (reported)April 3, 2026
Actual (reported)April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Physiological Heat Tolerance
Maximum tolerable exposure time during the standardized heat and ultraviolet radiation protocol. (units of measure: Minutes)
During 4-hour laboratory protocol
Heart Rate Response
Heart rate measured continuously during heat and UV exposure to assess cardiovascular strain \[unit: beats per minute (bpm)\]
During 4-hour laboratory protocol
Blood Pressure Response
During 4-hour laboratory protocol
Participants undergo a standardized 4-hour laboratory protocol to assess physiological and psychological responses to controlled heat and ultraviolet radiation exposure. The protocol includes passive heat exposure (40°C, 30% relative humidity), simulated solar UV radiation (up to 3 Standard Erythema Doses), light exercise-induced heat stress, and recovery. Core and skin temperature, cardiovascular and thermoregulatory responses, orthostatic tolerance, echocardiography, blood and urine biomarkers, skin biopsies, motor-cognitive performance, and psychological measures are assessed repeatedly. Subgroup analyses compare participants by geographic location (Denmark vs Greece) and pre-defined heat tolerance status (low vs high).
Participants undergo a standardized 4-hour laboratory-based environmental exposure protocol consisting of passive heat exposure (40°C, 30% relative humidity), simulated solar ultraviolet radiation (up to 3 Standard Erythema Doses), light exercise-induced heat stress using a cycle ergometer, and recovery. Physiological, cardiovascular, thermoregulatory, biochemical, and psychological responses are assessed repeatedly throughout the protocol. The intervention is designed to quantify individual heat tolerance and combined heat-UV physiological strain under controlled conditions.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Københavns Universitet
Copenhagen, 2100, Denmark
Department of Physical Education and Sport Science
Trikala, Thessaly, 42100, Greece
Andreas D Flouris, PhD
1FAME Laboratory, Department of Exercise Science, University of Thessaly, Trikala, Greece
Lars Nybo, PhD
Department of Nutrition, Exercise and Sports, August Krogh Building, University of Copenhagen, Copenhagen, Denmark.
First Submitted
February 20, 2026
First Posted
April 3, 2026
Study Start
November 1, 2025
Actual (reported)Cardiac Output
During 4-hour laboratory protocol
Orthostatic Tolerance
Every 60 min during the protocol
Echocardiographic Parameters
Every 60 min during the protocol
Contact the study team to confirm eligibility.
Primary Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 30, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
April 3, 2026
Record last verified: 2026-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: